AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

In Vitro Toxicity Testing: Technologies and Global Markets, 2019-2023 - Opportunities Presented by the Paradigm Shift in Toxicity Testing in the 21st Century - ResearchAndMarkets.com

March 12, 2019

DUBLIN--(BUSINESS WIRE)--Mar 12, 2019--The “In Vitro Toxicity Testing: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.

The increasing need for non-animal tests in toxicity testing is driving demand in the in vitro toxicity market.

The growing demand for in vitro toxicity testing during the drug discovery process and increasing number of contract research organizations (CRO) are major drivers of the global in vitro toxicity market.

The increasing demand for animal-free toxicity tests driving the growth of the global in vitro toxicity market. In vitro toxicity tests are reliable, cost-effective and do not use animals, unlike in vivo tests.

The rising global prevalence of chronic diseases has significantly increased demand for the discovery of novel drugs. The toxicity study of drugs and compounds is performed by the regulatory bodies, in order to facilitate the approval of drugs and devices.

The high cost of toxicology equipment, inadequate infrastructure and funding for R&D in emerging countries are expected to hinder the growth of the global in vitro toxicity market. High-throughput screening (HTS) equipment is expensive, particularly for small and emerging countries that wish to purchase multiple instruments. Their high cost may hinder market growth in these countries.

However, governments, companies and research institutes are extensively funding for toxicology research, which should overcome the cost challenges and drive market growth during the forecast period. Also, regulatory programs such as TOX21, ToxCast program and NTP (National Toxicology Program) are creating enormous opportunities for companies in the in vitro toxicity global market.

Charles River, GVK Biosciences Private Ltd., Sekisui XenoTech LLC and Merck KGaA are among a large number of CROs that offer in vitro toxicity services.

Key Market Growth Factors

  • Replacement of In Vivo Models, by In Vitro Models
  • In Vitro Toxicity in the Drug Discovery Process
  • CROs Gaining Popularity
  • Application of High-Throughput Screening in Toxicology

Opportunities

  • Extensive Funding, by Research Institutes on Toxicology
  • Paradigm Shift in Toxicity Testing in the 21st Century

Limitations & Challenges

  • Expensive Equipment Used in Toxicology

The report includes:

  • An overview of the global markets and technologies for the in vitro toxicity testing techniques within the pharmaceutical industry
  • Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on the latest trends, technological developments and government regulations that influence the growth of the market
  • A breakdown of influential factors, such as the validation of alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives
  • Evaluation covering equipment, assays, cells, reagents, and services used in toxicity testing
  • Profiles of major players in the toxicology market

Topics Covered

Chapter 1 Introduction

Chapter 2 Summary & Highlights

Chapter 3 Market & Technology Background

Chapter 4 Market Breakdown by Toxicity Endpoints & Tests

Chapter 5 Market Breakdown by End-User Industry

Chapter 6 Market Breakdown by Tool/Technology

Chapter 7 Market Breakdown by Component

Chapter 8 Market Breakdown by Region

Chapter 9 Patent Review/New Developments

Chapter 10 Company Profiles

  • Abbott Laboratories
  • Acea Biosciences
  • Agilent Technologies
  • Albany Molecular Research
  • Aptuit
  • Biognosys
  • Bioreliance
  • Biovia
  • Chantest
  • Charles River Laboratories
  • Covance
  • Cyprotex
  • Drik
  • Enzo Life Sciences
  • Eurofins Scientific
  • Evotec
  • GE Healthcare Life Sciences
  • Genedata
  • Gentronix
  • Hurel Corp.
  • Imquest Biosciences
  • Imstar
  • Insphero
  • Kiyatec
  • Lonza Group
  • Metabolon
  • Molecular Devices
  • Perkinelmer
  • Promega Corp.
  • Qiagen
  • SGS-SA
  • Synvivo
  • Thermo Fisher Scientific
  • Vala Sciences
  • Xenometrix
  • and more...

For more information about this report visit https://www.researchandmarkets.com/research/kcb37m/in_vitro_toxicity?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190312005469/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:In Vitro Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/12/2019 07:51 AM/DISC: 03/12/2019 07:51 AM

http://www.businesswire.com/news/home/20190312005469/en